The trial evaluated the safety, pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme’s Enhanze technology in hereditary angioedema (HAE). Enhanze technology is a drug
According to Sacbee, the companies marketing over-the counter (OTC) HCG products were issued seven warning Letters by FDA and FTC. There are no FDA-approved HCG drug products for
Under the agreement, Beactica will use its drug discovery platform, Sprint, to identify high-quality fragment hits against a number of undisclosed targets of therapeutic interest to Almac Discovery.
Lixisenatide is an investigational once-daily GLP-1 peptide agonist, found to suppress glucagon secretion from pancreatic alpha cells and enhance insulin secretion by pancreatic beta cells. The 24-week randomised
According to Pharmabiz, the studies involved the application of Malvern’s light scattering technologies in evaluating the formulation stability of Albucult and Recombumin. The teams applied the resolving capabilities
The Company has also appointed Rajeev Venkayya as its leader of the Division effective 15 January 2012. Dr Venkayya currently serves as Director of Vaccine Delivery in the
The new refrigerated AutoCarousel HD ensures medications are kept at a safe temperature in the central pharmacy, minimising energy costs and improving efficiency. Parkview Health System Pharmacy director
Run by Russian executives, FDS Pharma owns patents to vaccines and produces active pharmaceutical ingredients (APIs) for the Russian and other markets, according to globes.co.il. Singapore-based SciGen, a
The Nauzelin OD Tablets formulation includes Nauzelin OD Tablets 5 and Nauzelin OD Tablets 10. The new Nauzelin orally disintegrating tablet formulation has been developed by Kyowa Hakko
Sagnieres’ chairman and CEO position will be effective from 2 January 2012. Since 1 January 2010, Hubert Sagnieres has served at Essilor as CEO and chief operating officer
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.